Sofosbuvir Activates EGFR-Dependent Pathways in Hepatoma Cells with Implications for Liver-Related Pathological Processes

Direct acting antivirals (DAAs) revolutionized the therapy of chronic hepatitis C infection. However, unexpected high recurrence rates of hepatocellular carcinoma (HCC) after DAA treatment became an issue in patients with advanced cirrhosis and fibrosis. In this study, we aimed to investigate an imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Bojkova, Denisa, Westhaus, Sandra, Costa, Rui, Timmer, Lejla, Funkenberg, Nora, Korencak, Marek, Streeck, Hendrik, Vondran, Florian, Broering, Ruth, Heinrichs, Stefan, Lang, Karl S, Ciesek, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225999/
https://www.ncbi.nlm.nih.gov/pubmed/32316635
http://dx.doi.org/10.3390/cells9041003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225999/
https://www.ncbi.nlm.nih.gov/pubmed/32316635
http://dx.doi.org/10.3390/cells9041003

Ejemplares similares